首页 > 市场调查报告书 > 医疗设备

纤维

市场调查报告书

商品编码

1529386

全球生物医用纺织品市场 - 2024-2031

Global Biomedical textiles market - 2024-2031

出版日期: 2024年08月06日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球生物医用纺织品市场达到178亿美元，预计2031年将达288亿美元，2024-2031年预测期间复合年增长率为6.2%。

生物医用纺织品是基于纤维的医疗设备，可以植入患者体内以恢復组织特性，提供机械支撑，并促进各种适应症的癒合过程。以织物为基础的植入式医疗器材包括但不限于缝线、网片、血管移植物和心臟瓣膜。

生物医学纺织品可以由合成或天然来源製成，并且根据医疗器械的预期用途可以是不可再吸收的或可再吸收的。生物医学纺织品可以透过四种主要加工方法建构：针织、机织、编织和非织造方法。

生物医学纺织品市场涉及专门为医学和生物应用设计的纺织品的生产和使用。这些纺织品用于各种医疗领域，包括伤口护理、植入物、手术缝线和医疗保健织物。它们经过精心设计，可与生物系统相互作用，并具有生物相容性、抗菌特性、耐用性以及促进癒合和组织再生的能力等性能特征。

市场动态：

司机

人口老化加剧、慢性病盛行率增加、外科手术数量增加

全球生物医用纺织品市场的需求受到多重因素驱动。人口老化的不断加剧、慢性病的流行以及外科手术数量的增加也促进了市场的扩大。

全球不断增长的老龄化人口正在推动对医疗保健服务和产品的需求。随着老年人口的增加，对伤口护理、矫形支持和其他适应年龄相关状况的生物医学纺织品的需求更大。此外，糖尿病和心血管疾病等慢性病的流行进一步推动了对用于伤口管理和治疗的生物医用纺织品的需求。

此外，关键参与者的策略（例如伙伴关係和协作）将推动该市场的成长。例如，2022年4月，Integer Holdings Corporation宣布收购Connemara Biomedical Holdings Teoranta，包括其营运子公司Aran Biomedical及Proxy Biomedical。透过利用符合我们策略的此次收购，与Aran 的合併进一步增强了Integer 为高成长心血管市场（如结构性心臟、神经血管、週边血管和血管内以及普通外科）的复杂输送和治疗设备提供完整解决方案的能力。

手术数量的增加和对高品质伤口敷料材料的需求预计将推动生物医用纺织品市场。使用生物医用纺织品可以治疗受损的组织或器官，这是与生物医用纺织品相关的先进医学发明的结果。

限制

高研发投资、原材料短缺、个人缺乏意识以及监管挑战等因素预计将阻碍市场发展。

有关此报告的更多详细资讯 - 索取样品

Biomedical textiles are fiber-based medical devices that can be implanted in patients to restore tissue properties, provide mechanical support, as well as facilitate the healing process for a variety of indications. Textile-based implantable medical devices include but are not limited to sutures, meshes, vascular grafts, and heart valves.

Biomedical textiles may be created from synthetic or natural sources and may be non-resorbable or resorbable based on the medical device's intended use. Biomedical textiles may be constructed by four main processing methods knitting, weaving, braiding, and non-woven methods.

The biomedical textiles market involves the production and use of textile products designed specifically for medical and biological applications. These textiles are used in various medical fields, including wound care, implants, surgical sutures, and healthcare fabrics. They are engineered to interact with biological systems and are designed for performance characteristics such as biocompatibility, antimicrobial properties, durability, and the ability to promote healing and tissue regeneration.

Market Dynamics: Drivers

Growing aging population & prevalence of chronic diseases and rising number of surgical procedures

The demand for the global biomedical textiles market is driven by multiple factors. The growing aging population & the prevalence of chronic diseases and the rising number of surgical procedures are also contributing to the expansion of the market.

The growing aging population globally is driving the demand for healthcare services and products. As the elderly population increases, there is a greater need for wound care, orthopedic support, and other biomedical textiles that cater to age-related conditions. In addition, the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, further fuels the demand for biomedical textiles for wound management and treatment.

Moreover, key players' strategies such as partnerships & collaborations would drive this market growth. For instance, in April 2022, Integer Holdings Corporation announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical. By using this acquisition consistent with our strategy, the combination with Aran further increases Integer's ability to offer complete solutions for complex delivery and therapeutic devices in high-growth cardiovascular markets such as structural heart, neurovascular, peripheral vascular, and endovascular as well as general surgery.

The increasing number of surgeries and the demand for high-quality wound dressing material are expected to drive the biomedical textiles market. With the use of biomedical textiles, damaged tissues or organs can be treated, which is a result of advanced medical inventions related to biomedical textiles.

Restraints

Factors such as high R&D investments, shortages of raw materials, lack of awareness among individuals, and regulatory challenges are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global biomedical textiles market is segmented based on fiber, fabric, application, and region.

The non-biodegradable fiber segment accounted for approximately 56.6% of the global biomedical textiles market share

The non-biodegradable fiber segment is expected to hold the largest market share over the forecast period. These are the fibers that are not degraded by biological conditions for a long time and are mostly used for external purposes. These include polytetrafluoroethylene (PTFE), polyester, polypropylene, carbon, and others. Non-biodegradable fibers are used for applications where long-lasting performance is required, such as in surgical sutures, wound dressings, and implantable devices.

These sutures provide the necessary support to hold tissues together during the healing process, making them indispensable in surgical procedures. Their resistance to degradation ensures that they maintain structural integrity in medical applications, which is critical for patient safety and efficacy of treatment.

In addition, key players in the industry's innovative developments propel this segment's growth. For instance, in August 2022, The RGE-NTU SusTex project aims to accelerate innovation in textile recycling and translate research outcomes into practical solutions that can be deployed in urban settings like Singapore. Researchers in the S$6m joint research center will look into areas such as next-generation eco-friendly and sustainable textiles and refabricating textile waste into fiber. The aim is to study the chemistry of various textile materials and determine the optimal processes and techniques required to start a circular textile economy.

Geographical Analysis

North America accounted for approximately 45.7% of the global biomedical textiles market share

North America region is expected to hold the largest market share over the forecast period increasing the prevalence of chronic diseases, advancements in healthcare technology, and well-established healthcare infrastructure help to drive this market growth.

According to the National Institutes of Health, in June 2023, a significant portion of the U.S. population suffered from conditions requiring advanced medical interventions, which in turn drives the demand for biomedical textiles. For instance, the growing number of surgeries related to obesity and cardiovascular issues necessitates the use of specialized textiles for surgical applications.

Moreover, a major number of key players' presence and key developments in biomedical textiles propel this market growth in this region. For instance, in March 2024, Integra LifeSciences Holdings Corporation announced that MicroMatrix Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.

Also, in October 2022, Cortland Biomedical unveiled new capabilities for creating textile structures incorporating radiopaque fibers. Incorporating radiopaque fibers into diagnostic and interventional medical devices enables the devices to become visible under fluoroscopy.

Market Segmentation

By Fiber

Non-biodegradable Fiber
Biodegradable Fiber
Others

By Fabric

Woven
Non-woven
Others

By Application

Implantable
Non-implantable
Surgical Sutures
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- The rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the biomedical textiles market include Bally Ribbon Mills, Medical Murray, Indorama Corporation, Confluent Medical Technologies, ARAN BIOMEDICAL TEORANTA, Poly-Med Incorporated, CORTLAND BIOMEDICAL, Secant Group, Integer Holdings Corporation and Swicofil AG among others.

Key Developments

In June 2023, AccYouRate launched a smart T-shirt capable of providing real-time online monitoring of the body's vital signals. The 100% textile e-shirt measures ECG (including heart rate), breathing frequency and depth, body temperature, accelerometer, GPS, and body position, which enables fall alerts.
In February 2021, Ahlstrom-Munksjo launched a new product portfolio, which consists of a full suite of fabrics for medical and civil use face masks, including biodegradable and compostable materials such as PLA and cellulosic. The TenderGuard product portfolio consists of exceptionally soft, comfortable, and protective fabrics including TenderGuard BioBased and BioFilter fabrics, which are designed for civil use and source control for infectious diseases.

Why Purchase the Report?

To visualize the global biomedical textiles market segmentation based on fiber, fabric, application, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the biomedical textiles market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global biomedical textiles market report would provide approximately 62 tables, 53 figures, and 183 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Fiber
3.2. Snippet by Fabric
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Aging Population & Prevalence of Chronic Diseases and Rising Number of Surgical Procedures
  - 4.1.1.2. Growing Need for High-Quality Wound Dressing Material
- 4.1.2. Restraints
  - 4.1.2.1. High R&D Investments
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Fiber

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 6.1.2. Market Attractiveness Index, By Fiber
6.2. Non-biodegradable Fiber *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Biodegradable Fiber
6.4. Others

7. By Fabric

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 7.1.2. Market Attractiveness Index, By Fabric
7.2. Woven*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-woven
7.4. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Market Attractiveness Index, By Application
8.2. Implantable *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Non-implantable
8.4. Surgical Sutures
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Bally Ribbon Mills *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medical Murray
11.3. Indorama Corporation
11.4. Confluent Medical Technologies
11.5. ARAN BIOMEDICAL TEORANTA
11.6. Poly-Med Incorporated
11.7. CORTLAND BIOMEDICAL
11.8. Secant Group
11.9. Integer Holdings Corporation
11.10. Swicofil AG

LIST NOT EXHAUSTIVE